You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

spliceosome mutation

Showing 1 - 25 of 2,569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

Recruiting
  • Metastatic Solid Tumor
  • +4 more
  • Recommendation for treatment with immunotherapy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 8, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

GENOMED4ALL: Improving MDS Classification and Prognosis by AI

Active, not recruiting
  • Myelodysplastic Syndromes
    • Milano, Italy
      Istituto Clinico Humanitas
    Jun 28, 2021

    SRSF2 Gene Mutation in Patients With t-MDS/AML

    Completed
    • Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
    • PCR and cytogenetics
    • Assiut, Egypt
    • +1 more
    May 17, 2020

    SMN Circular RNAs as Potential Biomarkers for Therapeutic

    Recruiting
    • Spinal Muscular Atrophy
      • Rome, Italy/rome, Italy
        ethics committee of IRCCS Fondazione Policlinico Gemelli
      Mar 10, 2023

      Taybi Linder Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Types I and III, Roifman Syndrome Trial in France

      Not yet recruiting
      • Taybi Linder Syndrome
      • +3 more
      • Blood samples
      • +2 more
      • Bordeaux, France
      • +5 more
      Oct 26, 2023

      The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

      Recruiting
      • Beta-Thalassemia
      • ARMS PCR
      • Assiut, Egypt
        Faculty of Medicine Assiut University
      Jan 30, 2023

      Predictive Cancer Model Trial in Prague (colonoscopy)

      Recruiting
      • Predictive Cancer Model
      • colonoscopy
      • Prague, Czechia
        Military University Hospital
      Jun 25, 2023

      Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

      Recruiting
      • Advanced or Metastatic Solid Tumor
      • KRAS G12C Mutation
      • Changsha, Hunan, China
        Xiangya Hospital of Central South University
      Nov 2, 2023

      GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

      Not yet recruiting
      • GATA2 Gene Mutation
      • Biological samples (blood and bone marrow samples).
      • Angers, France
      • +16 more
      Jul 31, 2023

      Advanced Solid Tumor Trial in Guangzhou (YL-17231)

      Recruiting
      • Advanced Solid Tumor
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Oct 5, 2023

      Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Vienna, Austria
      • +3 more
      Jun 8, 2023

      Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

      Recruiting
      • Breast Cancer
      • Genetic Predisposition
      • Genetic predisposition to breast cancer
      • Rome, Italy
      • +1 more
      May 4, 2023

      Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

      Active, not recruiting
      • Cystic Fibrosis
      • Birmingham, Alabama
      • +169 more
      Dec 22, 2022

      DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

      Not yet recruiting
      • DDX41 Gene Mutation
      • For each person (index case or related) included in this study:
      • Bordeaux, France
      • +4 more
      Aug 28, 2023

      Carotid Plaque Burden in Philadelphia Negative

      Recruiting
      • Myeloproliferative Neoplasm
        • Sohag, Egypt
          Faculty of Medicine
        Aug 14, 2023

        Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

        Recruiting
        • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
        • Montpellier, France
        • +7 more
        Dec 19, 2022

        Myeloid Leukemia, MDS Trial (IFN-?)

        Not yet recruiting
        • Myeloid Leukemia
        • Myelodysplastic Syndromes
        • (no location specified)
        Nov 15, 2023

        Breast Cancer Trial in New York (core needle biopsy, blood draw)

        Recruiting
        • Breast Cancer
        • core needle biopsy
        • blood draw
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Nov 9, 2023

        NSCLC Trial in Guangzhou (PLB1001)

        Active, not recruiting
        • Non-small Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Aug 15, 2023

        Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

        Not yet recruiting
        • Leber Hereditary Optic Neuropathy (LHON)
        • NFS-02 Injection
        • (no location specified)
        Apr 6, 2023

        Trial

        Not yet recruiting
        • Leber Hereditary Optic Neuropathy (LHON)
        • NR082 Injection
        • Injection needle
        • (no location specified)
        Jan 30, 2023

        Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

        Recruiting
        • Advanced Solid Tumors
        • Grand Rapids, Michigan
        • +39 more
        Jan 25, 2023

        NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

        Active, not recruiting
        • Non-small Cell Lung Cancer Metastatic
        • Non-small Cell Lung Cancer Stage III
        • La Jolla, California
        • +5 more
        Aug 12, 2022